Medtronic, Inc. has announced the launch of iPro™2 Professional CGM, a continuous glucose monitoring (CGM) system used by physicians to help improve diabetes management, in 49 countries around the world. This simplified, yet more advanced fourth-generation CGM system is valuable for detecting high and low glucose fluctuations that can lead to dangerous health complications, which often go undetected with traditional A1C tests and glucose meter measurements.

Read the full story here

Medtronic Inc. has received FDA approval for its CGMS iPro Recorder, a new physician use continuous glucose monitoring system. The CGMS iPro Recorder records the glucose pattern in a patient, who is advised to wear it for three days. The data is then reviewed by physicians to uncover glucose patterns in the patient and optimize therapy. The device is reimbursable by Medicare.